Indogulf Cropsci
Indogulf Cropsci Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
The company is aspiring for 30% to 35% year-over-year revenue growth for FY26 and beyond, aiming for similar growth in FY27 and FY28. FY26 revenue growth aspiration: 30% to 35% year-over-year, continuing similar trajectory in FY27 and FY28.
From Indogulf Cropsci's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company is aspiring for 30% to 35% year-over-year revenue growth for FY26 and beyond, aiming for similar growth in FY27 and FY28.
- Growth is driven by new product launches, geographic expansion, and increased penetration of the B2C segment, especially in Q2 and Q4.
- New products launched recently contribute significantly; 9 products launched this year are expected to drive revenue growth.
- B2C revenue is expected to grow, with INR 180-200 crores targeted in Q2 FY26.
- Expansion of manufacturing capacity by 50-60% by fiscal end will support higher sales volumes and revenue.
- Biologicals and nutrients segments are expected to see aggressive growth of 30-40%.
2 more points from Indogulf Cropsci's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Indogulf Cropsci said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current and upcoming capex includes a dry flowable plant at Sonipat, Haryana, expected to be commissioned within FY26, costing around INR 14 crores.
- An additional INR 63 crores capex is underway for expanding capacity, including the establishment of a fifth manufacturing unit.
- Overall capex combining these is approximately INR 77 crores, aimed at increasing capacity by 50%-60%.
- The new facility is expected to start operations by the end of FY26.
- Payback period for this capex is estimated at 4 to 5 years at the EBITDA level.
- Peak sales capacity post-expansion projected between INR 1,700 crores to INR 2,000 crores.
2 more points from Indogulf Cropsci's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Indogulf Cropsci said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The document does not explicitly provide current or expected order book or pending orders figures.
- However, Q2 is noted as the highest utilization period due to a large number of orders and sales momentum, especially in B2C.
- Capacity utilization averages 50% to 60%, rising in Q2 when order volumes peak.
- The management is optimistic about revenue growth and efficiency improvements with new facilities coming online by the fiscal year-end.
- Q2 sales are projected to be strong, with expected revenues around INR 300 crores, reflecting over 20-25% growth, implying a healthy order pipeline.
2 more points from Indogulf Cropsci's call on order book
Pro opens every point from 15K+ earnings calls
Indogulf Cropsci — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹109 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Indogulf Cropsciences Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Sumitomo Chemical India Ltd (Q1 FY26)
1,056.8 crore, up 26% YoY from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
- Sharda Cropchem Ltd (Q1 FY26)
In Q1 FY 2026, revenue grew 25% year-on-year to Rs. Key concall takeaways from Sharda Cropchem Ltd's Q1 FY26 earnings call — and how it ranks against sector…
- Paradeep Phosphates Ltd (Q1 FY26)
Q1 volume growth was strong at 34% YoY; NPK volumes grew 48% (Pages 4, 14). Key concall takeaways from Paradeep Phosphates Ltd's Q1 FY26 earnings call — and…
- Meghmani Organics Ltd (Q1 FY26)
Utilization in crop protection plants is currently around 76-77%; growth will be driven by higher-value products and increased conversion into formulations…
Arthneeti Pro · Annual
Indogulf Cropsci and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Indogulf Cropsci Q1 FY26 results?
The company is aspiring for 30% to 35% year-over-year revenue growth for FY26 and beyond, aiming for similar growth in FY27 and FY28. FY26 revenue growth aspiration: 30% to 35% year-over-year, continuing similar trajectory in FY27 and FY28.
What is Indogulf Cropsci share price analysis?
Indogulf Cropsci currently shows a neutral. The stock trades at a P/E of 11.6 with a market cap of ₹448 Cr. Investors should review the full earnings analysis for detailed insights.
Is Indogulf Cropsci planning capital expenditure?
Current and upcoming capex includes a dry flowable plant at Sonipat, Haryana, expected to be commissioned within FY26, costing around INR 14 crores.
Keep Indogulf Cropsci on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.